Our Recommendations
- Post-Kala-Azar Dermal Leishmaniasis: A Manual for Case Management and Control (2013)
- Guideline for the Treatment of Leishmaniasis in the Americas (2022)
- Standard operating procedures for supply chain management of health products for neglected tropical diseases amenable to preventive chemotherapy (2022)
- Skin NTDs App (2024)
New Publications
- Elimination of kala-azar as a public health problem in South-East Asia: template dossier (2025)
- Skin NTDs App (2024)
- Élimination de la leishmaniose viscérale en tant que problème de santé publique au Kenya – progrès et défis (2024)
- Report of the first WHO global meeting on skin-related neglected tropical diseases (2024)
- New hope for leishmaniasis (2022)
Filter
83
Featured
Recommendations
4
New Publications
2
Language
Document type
Studies & Reports
21
Videos
16
Resource Platforms
15
Guidelines
11
Infographics
5
Fact sheets
5
Strategic & Response Plan
4
Manuals
3
Training Material
1
Dashboards/Maps
1
App
1
Countries / Regions
Global
33
Latin America and the Carribbean
9
Middle East and North Africa
4
Brazil
3
Sudan
3
Colombia
2
Kenya
2
South–East Asia Region
2
Bangladesh
2
Ethiopia
2
South Sudan
2
Somalia
2
India
2
Nepal
1
Turkey
1
China
1
Syria
1
Iran
1
Albania
1
Morocco
1
Africa
1
Asia
1
Jordan
1
Saudi Arabia
1
Western and Central Europe
1
Paraguay
1
Tunisia
1
East and Southern Africa
1
Lebanon
1
Eastern Europe
1
Greece
1
Georgia
1
Iraq
1
Pakistan
1
Authors & Publishers
Publication Years
Category
Leishmaniasis
18
Guidelines
5
Studies & Reports
4
Disease Prevention & Control
4
Vector Control
3
Pharmacy & Technologies
2
Buruli Ulcer
1
Dermatology
1
x MEDBOX Issue Brief & Annual Reports x
1
Health System Strengthening
1
Chagas
1
NTDs & Others
1
Toolboxes
Information & Education Material (IEC)
31
Studies & Reports
18
Clinical Aspects & Diagnostics
17
Statistics & Facts
13
Capacity Building & Resources
10
Prevention & Control
2
This template dossier complements and should be used after fulfilling the criteria and preconditions specified in the Process of validation of elimination of kala-azar as a public health problem in South-East Asia. The national kala-azar programme should be in the consolidation phase of elimination;...
Skin NTDs App
recommended
Recognizing neglected tropical diseseases through changes on the skin.
App for Android and IOS, free of charge. The App is available in English and French, with plans to explore translations into other languages, such as Portuguese and Spanish, to better serve diverse communities.
A patient's skin...
Available in French and English
The World Health Organization (WHO) organized the first global meeting on skin-related neglected tropical diseases (skin NTDs) at its headquarters in Geneva, Switzerland on 27–31 March 2023. This 5-day hybrid meeting brought together more than 800 global experts, stakeholders and partners from 86 ...
Leishmaniasis is a climate-sensitive disease. Changes in temperature, rainfall, and humidity can have strong impacts on
the sandfly vector, altering their distribution and influencing their survival and population sizes. Increased temperatures shorten vector development time, reduce Leishmania para...
This technical report presents the epidemiology of human and animal leishmaniases in the EU and its neighbouring countries and concludes that the disease remains widespread and underreported in many countries of southern Europe, northern Africa, and the Middle East and that there is a need to improv...
J Glob Health Sci. 2020 Jun;2(1):e3. A group of enzootic and zoonotic protozoan infections, the leishmaniases constitute among the most severely neglected tropical diseases (NTDs) and are found in all continents except Oceania. Representing the most common infectious diseases, NTDs comprise an open-...
Localized cutaneous leishmaniasis and its evolving forms (diffuse cutaneous leishmaniasis, mucosal leishmaniasis and cutaneous leishmaniasis recidivans), together with the sequela of visceral leishmaniasis (post-kala-azar dermal leishmaniasis), account for about one million cases of dermal leishmani...
During the Programme Managers’ Review Meeting of Central and East Africa and South-East Asia (online meeting, June 2022), experts proposed additional regional and national subtargets related to VL incidence, as defined below. These targets can be revisited as progress is reviewed and access to dia...
Video last accessed on 04.06.2023
Video Dailymotion
Website last accessed on 04.06.2023
Youtube Video
Visceral leishmaniasis, the most severe form of leishmaniasis also known as kala-azar, is a life-threatening disease caused by Leishmania parasites which are transmitted by female sandflies. Visceral leishmaniasis causes fever, weight loss, spleen and liver enlargement, and, if not treated, death. P...
Tis first edition describes the standard operating procedures for health products for NTDs amenable to preventive chemotherapy and the medicines donated to treat them. These include albendazole for lymphatic filariasis and soil-transmitted helminthiases; azithromycin for trachoma and yaws; diethylca...
Despite the significant role of vector control in national leishmaniasis control programmes, the programmatic community perceives vector control as the weakest component of leishmaniasis control strategies in terms of resources, scientific evidence of the usefulness of interventions and capacity for...
In the Region of the Americas, the leishmaniases are a group of diseases caused by various species of Leishmania, which cause a set of clinical syndromes in infected humans that can involve the skin, mucosa, and visceral organs. The spectrum of clinical disease is varied and depends on the interacti...
The term leishmaniasis encompasses multiple clinical syndromes, including the cutaneous, mucosal, and visceral forms, which result from infection of macrophages in the dermis, in the naso-orpharyngeal mucosa, and throughout the reticuloendothelial system, respectively. The infection can range from a...
Leishmaniasis is among the most neglected diseases. The most common form is cutaneous leishmaniasis that forms lesions on the skin.
The only treatment available for cutaneous leishmaniasis is highly toxic. In some cases, patients have died because of the treatment, even though cutaneous leishmania...
Cutaneous Leishmaniasis (CL) is a painful disease that exerts a serious toll on societies around the world that are afflicted by it. Although not life-threatening, the skin ulcers and scars it causes can lead to isolation and psychosocial pathologies due to social stigma, and its occurrence is often...
1 billion people are at risk of infection with leishmaniasis, a neglected disease strongly linked to poverty. There’s no single, simple cure: current treatments are complex and need to be adapted to the form of the disease and geographical region.
2nd edition. These guidelines include several notable changes from the first edition. For cutaneous leishmaniasis, ketoconazole has been removed from the list of treatment options; the number of Leishmania species for which there is strong evidence for the efficacy of miltefosine has increased from ...
